What is the current Price Target for the DiaMedica Therapeutics Inc. stock?

The average DiaMedica Therapeutics Inc. target price is $9.67. This is 162.68% higher than the current stock price. The highest price target is 198.91%, the lowest is 117.39%. 3 Analysts have issued a price target DiaMedica Therapeutics Inc. 2026 .

How high will the DiaMedica Therapeutics Inc. stock rise?

No reliable answer can be given as to how high the DiaMedica Therapeutics Inc. stock will rise. The performance of stocks, including the DiaMedica Therapeutics Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the DiaMedica Therapeutics Inc. stock today?

The performance of DiaMedica Therapeutics Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the DiaMedica Therapeutics Inc. stock fall?

The decline in DiaMedica Therapeutics Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

DiaMedica Therapeutics Inc. Forecast, price target & analysts

$3.48

5.57% today

Nasdaq, Apr 04, 08:49 pm CET

ISIN

CA25253X2077

Symbol

DMAC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

DiaMedica Therapeutics Inc. Target price 2025 - Analyst rating & recommendation

DiaMedica Therapeutics Inc. Classifications & Recommendation:

Buy

100%

DiaMedica Therapeutics Inc. Price Target

Target Price	$9.67
Price	$3.68
Potential	162.68% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target DiaMedica Therapeutics Inc. 2026 . The average DiaMedica Therapeutics Inc. target price is $9.67. This is 162.68% register free of charge higher than the current stock price. The highest price target is $11.00 198.91% register free of charge , the lowest is $8.00 117.39% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend DiaMedica Therapeutics Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the DiaMedica Therapeutics Inc. stock has an average upside potential 2026 of 162.68% register free of charge . Most analysts recommend the DiaMedica Therapeutics Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.61	-0.89
	1.67%	45.90%
P/E		negative

1 Analysts have issued a DiaMedica Therapeutics Inc. forecast for earnings per share. The average DiaMedica Therapeutics Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.61	1.67%
2025	$-0.89 45.90% Unlock
2026	$-0.77 13.48% Unlock

Current	-6.12	36.30%
2025	-4.13 32.52% Unlock
2026	-4.78 15.74% Unlock

DiaMedica Therapeutics Inc....

Current DiaMedica Therapeutics Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 19 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 15 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 10 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 07 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 19 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 15 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 10 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 07 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now